HIV Citation List: April 12 - April 25, 2013

PubMed citations

1. Extreme Multidrug Resistant HIV-1 Protease with 20 Mutations Is Resistant to Novel Protease Inhibitors with P1-pyrrolidinone or P2-tris-THF. Agniswamy, J., C.H. Shen, Y.F. Wang, A.K. Ghosh, K.V. Rao, C.X. Xu, J.M. Sayer, J.M. Louis, and I.T. Weber. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23590295].
[PubMed]. HIV_0412-042513.

2. Increasing Extracellular Protein Concentration Reduces Intracellular Antiretroviral Drug Concentration and Antiviral Effect. Avery, L.B., M.A. Zarr, R.P. Bakshi, R.F. Siliciano, and C.W. Hendrix. AIDS Research and Human Retroviruses, 2013. [Epub ahead of print]. PMID[23601085].
[PubMed]. HIV_0412-042513.

3. Highly Stereoselective Cyclopropanation of alpha,beta-Unsaturated Carbonyl Compounds with Methyl (Diazoacetoxy)acetate Catalyzed by a Chiral Ruthenium(II) Complex. Chanthamath, S., S. Takaki, K. Shibatomi, and S. Iwasa. Angewandte Chemie, 2013. [Epub ahead of print]. PMID[23592256].
[PubMed]. HIV_0412-042513.

4. Phosphorylation of SAMHD1 by Cyclin A2/CDK1 Regulates Its Restriction Activity toward HIV-1. Cribier, A., B. Descours, A.L. Valadao, N. Laguette, and M. Benkirane. Cell Reports, 2013. [Epub ahead of print]. PMID[23602554].
[PubMed]. HIV_0412-042513.

5. Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer. Ehteshami, M., M. Nijhuis, J.A. Bernatchez, C.J. Ablenas, S. McCormick, D. de Jong, D. Jochmans, and M. Gotte. The Journal of Biological Chemistry, 2013. [Epub ahead of print]. PMID[23598281].
[PubMed]. HIV_0412-042513.

6. Time-dependent Interaction of Ritonavir in Chronic Use: The Power Balance between Inhibition and Induction of P-glycoprotein and Cytochrome P450 3A. Fukushima, K., S. Kobuchi, K. Mizuhara, H. Aoyama, K. Takada, and N. Sugioka. Journal of Pharmaceutical Sciences, 2013. [Epub ahead of print]. PMID[23589366].
[PubMed]. HIV_0412-042513.

7. A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis. Johnson, T.J., M.R. Clark, T.H. Albright, J.S. Nebeker, A.L. Tuitupou, J.T. Clark, J. Fabian, R.T. McCabe, N. Chandra, G.F. Doncel, D.R. Friend, and P.F. Kiser. Antimicrobial Agents & Chemotherapy, 2012. 56(12): p. 6272-6283. PMID[23006751].
[PubMed]. HIV_0412-042513.

8. Allosteric Integrase Inhibitor Potency Is Determined through the Inhibition of HIV-1 Particle Maturation. Jurado, K.A., H. Wang, A. Slaughter, L. Feng, J.J. Kessl, Y. Koh, W. Wang, A. Ballandras-Colas, P.A. Patel, J.R. Fuchs, M. Kvaratskhelia, and A. Engelman. Proceedings of the National Academy of Sciences of the United States of America, 2013. [Epub ahead of print]. PMID[23610442].
[PubMed]. HIV_0412-042513.

9. Protective Effect of Vaginal Application of Neutralizing and Nonneutralizing Inhibitory Antibodies against Vaginal SHIV Challenge in Macaques. Moog, C., N. Dereuddre-Bosquet, J.L. Teillaud, M.E. Biedma, V. Holl, G. Van Ham, L. Heyndrickx, A. Van Dorsselaer, D. Katinger, B. Vcelar, S. Zolla-Pazner, I. Mangeot, C. Kelly, R.J. Shattock, and R. Le Grand. Mucosal Immunology, 2013. [Epub ahead of print]. PMID[23591718].
[PubMed]. HIV_0412-042513.

10. A Novel anti-HIV Active Integrase Inhibitor with a Favorable in Vitro Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Metabolism Profile. Okello, M.O., S. Mishra, M. Nishonov, M.K. Mankowski, J.D. Russell, J. Wei, P.A. Hogan, R.G. Ptak, and V. Nair. Antiviral Research, 2013. [Epub ahead of print]. PMID[23602851].
[PubMed]. HIV_0412-042513.

11. Saquinavir-NO Inhibits S6 Kinase Activity, Impairs Secretion of the Encephalytogenic Cytokines Interleukin-17 and Interferon-gamma and Ameliorates Experimental Autoimmune Encephalomyelitis. Petkovic, F., J. Blazevski, M. Momcilovic, G. Timotijevic, M.B. Zocca, S. Mijatovic, D. Maksimovic-Ivanic, K. Mangano, P. Fagone, S. Stosic-Grujicic, F. Nicoletti, and D. Miljkovic. Journal of Neuroimmunology, 2013. [Epub ahead of print]. PMID[23602714].
[PubMed]. HIV_0412-042513.

12. Pyridine-substituted Desoxyritonavir Is a More Potent Inhibitor of Cytochrome P450 3A4 Than Ritonavir. Sevrioukova, I.F. and T.L. Poulos. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23586711].
[PubMed]. HIV_0412-042513.

13. Microbiological Transformation of the Triterpene Nigranoic Acid by the Freshwater Fungus Dictyosporium heptasporum. Sun, R., H.C. Song, Y.H. Yang, P. Yang, D.Y. Yang, K.Z. Shen, Y.B. Xu, Y.X. Gao, Y.G. Chen, and J.Y. Dong. Journal of Asian Natural Products Research, 2013. [Epub ahead of print]. PMID[23600754].
[PubMed]. HIV_0412-042513.

14. Towards the Enantioselective Synthesis of (-)-Euonyminol - Preparation of a Fully Functionalised Lower-rim Model. Webber, M.J., S.A. Warren, D.M. Grainger, M. Weston, S. Clark, S.J. Woodhead, L. Powell, S. Stokes, A. Alanine, J.P. Stonehouse, C.S. Frampton, A.J. White, and A.C. Spivey. Organic & Biomolecular Chemistry, 2013. 11(15): p. 2514-2533. PMID[23443742].
[PubMed]. HIV_0412-042513.

15. The Retroviral Restriction Ability of SAMHD1, but Not Its Deoxynucleotide Triphosphohydrolase Activity, Is Regulated by Phosphorylation. White, T.E., A. Brandariz-Nunez, J.C. Valle-Casuso, S. Amie, L.A. Nguyen, B. Kim, M. Tuzova, and F. Diaz-Griffero. Cell Host & Microbe, 2013. 13(4): p. 441-451. PMID[23601106].
[PubMed]. HIV_0412-042513.

16. Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection. Yan, J., S. Kaur, M. Delucia, C. Hao, J. Mehrens, C. Wang, M. Golczak, K. Palczewski, A.M. Gronenborn, J. Ahn, and J. Skowronski. The Journal of Biological Chemistry, 2013. 288(15): p. 10406-10417. PMID[23426366].
[PubMed]. HIV_0412-042513.

17. Sequence-controlled Multi-block Glycopolymers to Inhibit DC-SIGN-gp120 Binding. Zhang, Q., J. Collins, A. Anastasaki, R. Wallis, D.A. Mitchell, C.R. Becer, and D.M. Haddleton. Angewandte Chemie, 2013. 52(16): p. 4435-4439. PMID[23494988].
[PubMed]. HIV_0412-042513.

ISI Web of Knowledge Citations

18. POM as a Quick Bioinformatic Platform to Select Flavonoids and Their Metabolites as Potential and Efficient HIV-1 Integrase Inhibitors. Ben Hadda, T., T. Fergoug, I. Warad, V. Masand, and J. Sheikh. Research on Chemical Intermediates, 2013. 39(3): p. 1227-1244. ISI[000316008300034].
[WOS]. HIV_0412-042513.

19. Synthesis and Biological Activity of Analogues of Batzelladine F. Bennett, E.L., G.P. Black, P. Browne, A. Hizi, M. Jaffar, J.P. Leyland, C. Martin, I. Oz-Gleenberg, P.J. Murphy, T.D. Roberts, A.J. Thornhill, and S.A. Vale. Tetrahedron, 2013. 69(14): p. 3061-3066. ISI[000316516500024].
[WOS]. HIV_0412-042513.

20. High-throughput Sequence Analysis Reveals Structural Diversity and Improved Potency among RNA Inhibitors of HIV Reverse Transcriptase. Ditzler, M.A., M.J. Lange, D. Bose, C.A. Bottoms, K.F. Virkler, A.W. Sawyer, A.S. Whatley, W. Spollen, S.A. Givan, and D.H. Burke. Nucleic Acids Research, 2013. 41(3): p. 1873-1884. ISI[000316351800047].
[WOS]. HIV_0412-042513.

21. From the Chemistry of Epoxy-sugar Nucleosides to the Discovery of anti-HIV Agent 4 '-Ethynylstavudine--Festinavir. Haraguchi, K., S. Takeda, Y. Kubota, H. Kumamoto, H. Tanaka, T. Hamasaki, M. Baba, E. Paintsil, and Y.C. Cheng. Current Pharmaceutical Design, 2013. 19(10): p. 1880-1897. ISI[000316455200011].
[WOS]. HIV_0412-042513.

22. Synthesis and HIV-1 Inhibitory Activities of Dicaffeoyl and Digalloyl Esters of Quinic Acid Derivatives. Junior, C.O.R., S.C. Verde, C.A.M. Rezende, W. Caneschi, M.R.C. Couri, B.R. McDougall, W.E. Robinson, and M.V. de Almeida. Current Medicinal Chemistry, 2013. 20(5): p. 724-733. ISI[000316609900011].
[WOS]. HIV_0412-042513.

23. Antiretroviral Effect of 4-Thio-uridylate against Human Immunodeficiency Virus Type 1. Kanizsai, S., A. Ghidan, J. Ongradi, and K. Nagy. Acta Microbiologica Et Immunologica Hungarica, 2012. 59(4): p. 499-510. ISI[000316619300007].
[WOS]. HIV_0412-042513.

24. Iron-mediated Total Synthesis of 2,7-Dioxygenated Carbazole Alkaloids. Krahl, M.P., O. Kataeva, A.W. Schmidt, and H.J. Knolker. European Journal of Organic Chemistry, 2013. 2013(1): p. 59-64. ISI[000316189400008].
[WOS]. HIV_0412-042513.

25. High Throughput LC-MS/MS Method for Simultaneous Determination of Zidovudine, Lamivudine and Nevirapine in Human Plasma. Kumar, V.R., B.P.B. Reddy, B.R. Kumar, K. Sreekanth, and K.N. Babu. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 2013. 921: p. 9-14. ISI[000316515900002].
[WOS]. HIV_0412-042513.

26. Sp100 Interacts with HIV-1 Integrase and Inhibits Viral Integration. Lin, Y., Z.H. Li, R. Wang, W.J. Li, J.J. Wang, C.N. Ji, J.L. Xue, and J.Z. Chen. Progress in Biochemistry and Biophysics, 2013. 40(3): p. 240-248. ISI[000316652900006].
[WOS]. HIV_0412-042513.

27. Synthesis of Phospholipid--Ribavirin Conjugates. Oleynikova, I.A., T.I. Kulak, D.A. Bolibrukh, and E.N. Kalinichenko. Helvetica Chimica Acta, 2013. 96(3): p. 463-472. ISI[000316275500016].
[WOS]. HIV_0412-042513.

28. Bioprocessing of Plant in Vitro Systems for the Mass Production of Pharmaceutically Important Metabolites: Paclitaxel and Its Derivatives. Onrubia, M., R.M. Cusido, K. Ramirez, L. Hernandez-Vazquez, E. Moyano, M. Bonfill, and J. Palazon. Current Medicinal Chemistry, 2013. 20(7): p. 880-891. ISI[000316610600004].
[WOS]. HIV_0412-042513.

29. A Novel Method for Screening beta-Glucosidase Inhibitors. Pandey, S., A. Sree, S.S. Dash, and D.P. Sethi. BMC Microbiology, 2013. 13. ISI[000316245400001].
[WOS]. HIV_0412-042513.

30. A Readily Applicable Strategy to Convert Peptides to Peptoid-based Therapeutics. Park, M., M. Wetzler, T.S. Jardetzky, and A.E. Barron. Plos One, 2013. 8(3). ISI[000316546400014].
[WOS]. HIV_0412-042513.

31. Ionotropically Gelled Chitosan-alginate Complex Hydrogel Beads: Preparation, Characterization and in-Vitro Evaluation. Patil, J.S., M.V. Kamalapur, S.C. Marapur, S.S. Shiralshetti, and D.V. Kadam. Indian Journal of Pharmaceutical Education and Research, 2012. 46(3): p. 248-252. ISI[000316244300009].
[WOS]. HIV_0412-042513.

32. Linear and Cyclic Glycopeptide as HIV Protease Inhibitors. Pawar, S.A., A.M. Jabgunde, G.E.M. Maguire, H.G. Kruger, Y. Sayed, M.E.S. Soliman, D.D. Dhavale, and T. Govender. European Journal of Medicinal Chemistry, 2013. 60: p. 144-154. ISI[000316242700016].
[WOS]. HIV_0412-042513.

33. Synthesis and Crystal Structure Studies of Three N-phenylphthalimide Derivatives. Rauf, M.K., R. Mushtaq, A. Badshah, R. Kingsford-Adaboh, J. Harrison, and H. Ishida. Journal of Chemical Crystallography, 2013. 43(3): p. 144-150. ISI[000316292900006].
[WOS]. HIV_0412-042513.

34. The Development of Novel Inhibitors for the Treatment of HIV Infection. Tan, J.J. and C.X. Wang. Current Pharmaceutical Design, 2013. 19(10): p. 1765-1766. ISI[000316455200001].
[WOS]. HIV_0412-042513.

35. Discovery of Small Molecule Fusion Inhibitors Targeting HIV-1 gp41. Zhou, G.Y. and S.D. Chu. Current Pharmaceutical Design, 2013. 19(10): p. 1818-1826. ISI[000316455200006].
[WOS]. HIV_0412-042513.

36. Marine Natural Products with anti-HIV Activities in the Last Decade. Zhou, X.F., J. Liu, B. Yang, X.P. Lin, X.W. Yang, and Y.H. Liu. Current Medicinal Chemistry, 2013. 20(7): p. 953-973. ISI[000316610600009].
[WOS]. HIV_0412-042513.

Patent Search Citations

37. Topical Use of Hydroxytyrosol and Derivatives for the Prevention of HIV Infection. Gomez-Acebo, E., J.A. Pertejo, and D.A. Calles. Patent. 2012. US 20120260922A1.
[Espacenet]. HIV_0412-042513.